Understanding how antibodies fight influenza viruses
Sequence-function relationship of influenza broadly neutralizing antibodies
This study is looking at how certain antibodies in our bodies can fight off different types of the flu virus, with the goal of creating a universal flu vaccine that could protect everyone better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-11015412 on NIH RePORTER |
What this research studies
This research investigates the relationship between the genetic sequences of antibodies and their ability to neutralize various strains of the influenza virus. By focusing on broadly neutralizing antibodies that target conserved regions of the virus, the study aims to develop a universal influenza vaccine. The approach includes high-throughput experiments to analyze how these antibodies function against different influenza subtypes, which could lead to more effective vaccines for patients. Patients may benefit from advancements in vaccine development that could provide broader protection against influenza.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are at risk of influenza infection, including those with weakened immune systems or chronic health conditions.
Not a fit: Patients who are not at risk for influenza or those who have already been vaccinated with effective seasonal vaccines may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of a universal influenza vaccine that offers better protection against multiple strains of the virus.
How similar studies have performed: Previous research has shown promise in developing broadly neutralizing antibodies for other viruses, suggesting that this approach could be effective for influenza as well.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Wu, Nicholas C. — University of Illinois at Urbana-Champaign
- Study coordinator: Wu, Nicholas C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.